Timing of dornase alfa inhalation for cystic fibrosis.

Cochrane database of systematic reviews (Online)

Volumn 5, Issue , 2011, Pages

  Dentice, Ruth ^a   Elkins, Mark ^b  

^a ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

DEOXYRIBONUCLEASE I; DNASE1 PROTEIN, HUMAN;

ADOLESCENT; ADULT; ARTIFICIAL VENTILATION; CHILD; CYSTIC FIBROSIS; DRUG ADMINISTRATION; HUMAN; INHALATIONAL DRUG ADMINISTRATION; META ANALYSIS; METHODOLOGY; MULTIMODALITY CANCER THERAPY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; TIME;

ADMINISTRATION, INHALATION; ADOLESCENT; CHILD; COMBINED MODALITY THERAPY; CYSTIC FIBROSIS; DEOXYRIBONUCLEASE I; DRUG ADMINISTRATION SCHEDULE; HUMANS; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESPIRATORY THERAPY; TIME FACTORS; YOUNG ADULT;

EID: 79959525107     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: None     Document Type: Review

References (0)